These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27236803)

  • 1. Delivery of Synthetic mRNA Encoding FOXP3 Antigen into Dendritic Cells for Inflammatory Breast Cancer Immunotherapy.
    Devi GR; Nath S
    Methods Mol Biol; 2016; 1428():231-43. PubMed ID: 27236803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells.
    Van Tendeloo VF; Ponsaerts P; Lardon F; Nijs G; Lenjou M; Van Broeckhoven C; Van Bockstaele DR; Berneman ZN
    Blood; 2001 Jul; 98(1):49-56. PubMed ID: 11418462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.
    Bonehill A; Van Nuffel AM; Corthals J; Tuyaerts S; Heirman C; François V; Colau D; van der Bruggen P; Neyns B; Thielemans K
    Clin Cancer Res; 2009 May; 15(10):3366-75. PubMed ID: 19417017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An autologous therapeutic dendritic cell vaccine transfected with total lung carcinoma RNA stimulates cytotoxic T lymphocyte responses against non-small cell lung cancer.
    Wang K; Zhou Q; Guo AL; Xu CR; An SJ; Wu YL
    Immunol Invest; 2009; 38(7):665-80. PubMed ID: 19811429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic mRNA-based electrotransfection of autologous dendritic cells and specific antitumor effects against osteosarcoma in rats.
    Yu Z; Qian J; Wu J; Gao J; Zhang M
    Med Oncol; 2012 Dec; 29(5):3440-8. PubMed ID: 22843292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific antitumor effects of tumor vaccine produced by autologous dendritic cells transfected with allogeneic osteosarcoma total RNA through electroporation in rats.
    Yu Z; Sun H; Zhang T; Yang T; Long H; Ma B
    Cancer Biol Ther; 2009 May; 8(10):973-80. PubMed ID: 19287216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical scale electroloading of mature dendritic cells with melanoma whole tumor cell lysate is superior to conventional lysate co-incubation in triggering robust in vitro expansion of functional antigen-specific CTL.
    Wolfraim LA; Takahara M; Viley AM; Shivakumar R; Nieda M; Maekawa R; Liu LN; Peshwa MV
    Int Immunopharmacol; 2013 Mar; 15(3):488-97. PubMed ID: 23474736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination.
    Wei FQ; Sun W; Wong TS; Gao W; Wen YH; Wei JW; Wei Y; Wen WP
    J Exp Clin Cancer Res; 2016 Jan; 35():18. PubMed ID: 26795730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes.
    Grünebach F; Kayser K; Weck MM; Müller MR; Appel S; Brossart P
    Cancer Gene Ther; 2005 Sep; 12(9):749-56. PubMed ID: 15877082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of autologous tumor lysate-loaded dendritic cell vaccines by a closed-flow electroporation system for solid tumors.
    Kamigaki T; Kaneko T; Naitoh K; Takahara M; Kondo T; Ibe H; Matsuda E; Maekawa R; Goto S
    Anticancer Res; 2013 Jul; 33(7):2971-6. PubMed ID: 23780988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapy.
    Onaitis MW; Kalady MF; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK
    Surgery; 2003 Aug; 134(2):300-5. PubMed ID: 12947333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced dendritic cell antigen presentation in RNA-based immunotherapy.
    Kalady MF; Onaitis MW; Padilla KM; Emani S; Tyler DS; Pruitt SK
    J Surg Res; 2002 Jun; 105(1):17-24. PubMed ID: 12069496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer
    Chen J; Guo XZ; Li HY; Zhao JJ; Xu WD
    World J Gastroenterol; 2017 Feb; 23(5):817-829. PubMed ID: 28223726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mRNA-based dendritic cell vaccines.
    Benteyn D; Heirman C; Bonehill A; Thielemans K; Breckpot K
    Expert Rev Vaccines; 2015 Feb; 14(2):161-76. PubMed ID: 25196947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA loading of leukemic antigens into cord blood-derived dendritic cells for immunotherapy.
    Hsu AK; Kerr BM; Jones KL; Lock RB; Hart DN; Rice AM
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):855-67. PubMed ID: 16864056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in dendritic cell-based vaccine of cancer.
    Zhang X; Gordon JR; Xiang J
    Cancer Biother Radiopharm; 2002 Dec; 17(6):601-19. PubMed ID: 12537664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell vaccine with mRNA targeted to the proteasome by polyubiquitination.
    Hosoi A; Takeda Y; Sakuta K; Ueha S; Kurachi M; Kimura K; Maekawa R; Kakimi K
    Biochem Biophys Res Commun; 2008 Jun; 371(2):242-6. PubMed ID: 18423376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cytotoxic capacity of tumor antigen specific human T cells after in vitro stimulation with IL21 producing dendritic cells.
    Turksma AW; Bontkes HJ; Ruizendaal JJ; van den Heuvel H; Scholten KB; Santegoets SJ; de Gruijl TD; Meijer CJ; Hooijberg E
    Hum Immunol; 2013 May; 74(5):506-13. PubMed ID: 23376456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of cancer with dendritic cells loaded with tumor antigens and activated through mRNA electroporation.
    Van Nuffel AM; Corthals J; Neyns B; Heirman C; Thielemans K; Bonehill A
    Methods Mol Biol; 2010; 629():405-52. PubMed ID: 20387165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.